New monthly shot aims to block COVID-19 infection
NCT ID NCT07298434
Summary
This study is testing whether a new drug called VYD2311 can prevent people from getting COVID-19. About 1,770 adults and teens aged 12+ will receive three monthly shots of either VYD2311 or a placebo. Researchers will track who gets sick over 90 days to see if the drug lowers infection risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inviviyd Investigative Site
San Diego, California, 92103, United States
-
Invivyd Investigative Site
Long Beach, California, 90806, United States
-
Invivyd Investigative Site
Orlando, Florida, 32819, United States
-
Invivyd Investigative Site
Hinesville, Georgia, 31313, United States
-
Invivyd Investigative Site
Melrose Park, Illinois, 60160, United States
-
Invivyd Investigative Site
Lenexa, Kansas, 66219, United States
-
Invivyd Investigative Site
Silver Spring, Maryland, 20904, United States
-
Invivyd Investigative Site
Burlington, Massachusetts, 01803, United States
-
Invivyd Investigative Site
Southfield, Michigan, 48034, United States
-
Invivyd Investigative Site
Maplewood, Minnesota, 55109, United States
-
Invivyd Investigative Site
Independence, Missouri, 64055, United States
-
Invivyd Investigative Site
Jersey City, New Jersey, 07306, United States
-
Invivyd Investigative Site
The Bronx, New York, 10455, United States
-
Invivyd Investigative Site
Philadelphia, Pennsylvania, 19107, United States
-
Invivyd Investigative Site
Myrtle Beach, South Carolina, 29572, United States
-
Invivyd Investigative Site
Goodlettsville, Tennessee, 37072, United States
-
Invivyd Investigative Site
Houston, Texas, 77065, United States
-
Invivyd Investigative Site
Houston-2, Texas, 77065, United States
-
Invivyd Investigative Site
Irving, Texas, 75061, United States
-
Invivyd Investigative Site
Sugar Land, Texas, 46254, United States
Conditions
Explore the condition pages connected to this study.